Showing results (1-10 of 339) with videos related to
Sort By:
Pageof 34
Annals of the New York Academy of Sciences|February 8, 2006
CD154 gene therapy for human B-cell malignanciesDavorka Messmer, Thomas J KippsBreast Cancer Research : BCR|September 20, 2005
Treatment of solid tumors with immunotoxinsDavorka Messmer, Thomas J KippsBlood|December 21, 2012
Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemiaJessie-F Fecteau, Davorka Messmer, Suping Zhang, et al.Blood|November 17, 2010
Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenibDavorka Messmer, Jessie-F Fecteau, Morgan O'Hayre, et al.Molecular Medicine (Cambridge, Mass.)|October 8, 2011
Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1)Jessie-F Fecteau, Ila S Bharati, Morgan O'Hayre, et al.Plos One|July 28, 2010
Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysisMorgan O'Hayre, Catherina L Salanga, Thomas J Kipps, et al.Cytokine & Growth Factor Reviews|March 4, 2006
High-mobility group box 1 (HMGB1) protein: friend and foeLuis Ulloa, Davorka MessmerInternational Immunology|March 29, 2003
The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cellsDavorka Messmer, Bradley Messmer, Nicholas ChiorazziCancer Journal (Sudbury, Mass.)|August 16, 2021
Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic LeukemiaThomas J KippsSeminars in Oncology|February 14, 2002
Advances in classification and therapy of indolent B-cell malignanciesThomas J KippsPageof 34